Kenvue Inc. $KVUE Shares Acquired by Vestmark Advisory Solutions Inc.

Vestmark Advisory Solutions Inc. increased its position in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 119.5% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 21,946 shares of the company's stock after purchasing an additional 11,950 shares during the quarter. Vestmark Advisory Solutions Inc.'s holdings in Kenvue were worth $526,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Neuberger Berman Group LLC increased its position in shares of Kenvue by 252.7% in the first quarter. Neuberger Berman Group LLC now owns 936,264 shares of the company's stock valued at $22,452,000 after buying an additional 670,791 shares in the last quarter. Boston Partners lifted its stake in shares of Kenvue by 7.4% in the 1st quarter. Boston Partners now owns 25,346,453 shares of the company's stock valued at $606,920,000 after purchasing an additional 1,750,490 shares during the last quarter. Tokio Marine Asset Management Co. Ltd. lifted its stake in shares of Kenvue by 1.3% in the 1st quarter. Tokio Marine Asset Management Co. Ltd. now owns 58,322 shares of the company's stock valued at $1,399,000 after purchasing an additional 744 shares during the last quarter. National Pension Service lifted its stake in Kenvue by 2.3% during the 1st quarter. National Pension Service now owns 2,885,918 shares of the company's stock worth $69,204,000 after acquiring an additional 64,762 shares in the last quarter. Finally, Prudential PLC lifted its stake in Kenvue by 21.2% during the 1st quarter. Prudential PLC now owns 695,816 shares of the company's stock worth $16,686,000 after acquiring an additional 121,673 shares in the last quarter. Institutional investors and hedge funds own 97.64% of the company's stock.

Analysts Set New Price Targets

KVUE has been the topic of a number of analyst reports. Bank of America reduced their price target on Kenvue from $27.00 to $25.00 and set a "buy" rating on the stock in a research report on Tuesday, July 15th. JPMorgan Chase & Co. cut their price target on Kenvue from $27.00 to $26.00 and set an "overweight" rating on the stock in a research report on Friday, July 25th. Zacks Research upgraded Kenvue to a "strong sell" rating in a research note on Monday, August 11th. Canaccord Genuity Group reduced their price target on Kenvue from $29.00 to $26.00 and set a "buy" rating for the company in a report on Friday, August 8th. Finally, Royal Bank Of Canada reduced their price target on Kenvue from $24.00 to $22.00 and set a "sector perform" rating for the company in a report on Friday, August 8th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and five have given a buy rating to the company. Based on data from MarketBeat.com, Kenvue presently has a consensus rating of "Hold" and an average target price of $24.38.

Kenvue Stock Performance

Shares of NYSE KVUE opened at $21.15 on Monday. Kenvue Inc. has a 1 year low of $19.75 and a 1 year high of $25.17. The stock has a fifty day moving average price of $21.54 and a two-hundred day moving average price of $22.43. The firm has a market cap of $40.59 billion, a P/E ratio of 28.58, a PEG ratio of 3.05 and a beta of 0.83. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.68 and a current ratio of 0.98.

Kenvue (NYSE:KVUE - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The company reported $0.29 EPS for the quarter, beating analysts' consensus estimates of $0.28 by $0.01. Kenvue had a return on equity of 20.06% and a net margin of 9.37%. The company had revenue of $3.84 billion during the quarter, compared to the consensus estimate of $3.94 billion. During the same quarter in the prior year, the firm earned $0.32 EPS. The company's quarterly revenue was down 4.0% compared to the same quarter last year. Research analysts forecast that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, August 27th. Stockholders of record on Wednesday, August 13th will be issued a $0.2075 dividend. The ex-dividend date is Wednesday, August 13th. This is an increase from Kenvue's previous quarterly dividend of $0.21. This represents a $0.83 dividend on an annualized basis and a dividend yield of 3.9%. Kenvue's dividend payout ratio is currently 112.16%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.